Conference Coverage

Good definitions, research lacking for COPD-asthma overlap


 

EXPERT ANALYSIS FROM AAAAI/WAO JOINT CONGRESS


There is disagreement in published definitions: One set of definitions includes a criterion of fractional exhaled nitric oxide not seen in any other definitions, whereas some other definitions require a history of smoking while others don’t, he said.

“How does one manage a disease without a definition and without clinical studies? It’s impossible for me to know,” Dr. Peebles said.

Dr. R. Stokes Peebles

Dr. R. Stokes Peebles

A commentary piece published in 2016, he noted, called for the term ACOS to be “abandoned” and then replaced when new phenotypes and underlying subtypes are identified and when “a new taxonomy of airway diseases is generated.” Dr. Peebles said he agreed with this suggestion.

Jeffrey Drazen, MD, the Distinguished Parker B. Francis Professor of Medicine at Harvard Medical School, Boston, and the editor of the New England Journal of Medicine, also lamented the polar nature of the research.

Recommended Reading

Nebulized LABA safe for long-term use in COPD
MDedge Internal Medicine
FDA asked to approve add-on drug for eosinophilic COPD
MDedge Internal Medicine
Omalizumab helps asthma COPD overlap patients
MDedge Internal Medicine
Health disparities in rural America: Chronic conditions
MDedge Internal Medicine
Nebulized LAMA for COPD approved
MDedge Internal Medicine
FDA axes asthma drugs’ boxed warning
MDedge Internal Medicine
First month of LABA/LAMA ups cardiovascular risk
MDedge Internal Medicine
FDA approves starting dose of roflumilast
MDedge Internal Medicine
FDA’s standards for approving generics are questioned
MDedge Internal Medicine
House cleaning linked to lung function decline
MDedge Internal Medicine